FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

34819111000001102: Rivaroxaban 15mg tablets and Rivaroxaban 20mg tablets (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 08-Nov 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
105502401000001115 Rivaroxaban 15mg tablets and Rivaroxaban 20mg tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
105502501000001116 Rivaroxaban 15mg tablets and Rivaroxaban 20mg tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rivaroxaban 15mg tablets and Rivaroxaban 20mg tablets Has NHS dm+d (dictionary of medicines and devices) dose form indicator Not applicable dose form indicator true Inferred relationship Existential restriction modifier
Rivaroxaban 15mg tablets and Rivaroxaban 20mg tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rivaroxaban 15mg tablets and Rivaroxaban 20mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Route of administration not applicable true Inferred relationship Existential restriction modifier
Rivaroxaban 15mg tablets and Rivaroxaban 20mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) combination product indicator Combination product true Inferred relationship Existential restriction modifier
Rivaroxaban 15mg tablets and Rivaroxaban 20mg tablets Is a Rivaroxaban true Inferred relationship Existential restriction modifier
Rivaroxaban 15mg tablets and Rivaroxaban 20mg tablets Plays role Anticoagulant therapeutic role true Inferred relationship Existential restriction modifier
Rivaroxaban 15mg tablets and Rivaroxaban 20mg tablets Is a Product containing rivaroxaban false Inferred relationship Existential restriction modifier
Rivaroxaban 15mg tablets and Rivaroxaban 20mg tablets Has active ingredient Rivaroxaban false Inferred relationship Existential restriction modifier
Rivaroxaban 15mg tablets and Rivaroxaban 20mg tablets Has dispensed dose form Dose form not applicable (qualifier value) true Inferred relationship Existential restriction modifier
Rivaroxaban 15mg tablets and Rivaroxaban 20mg tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rivaroxaban 15mg tablets and Rivaroxaban 20mg tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rivaroxaban 15mg tablets and Rivaroxaban 20mg tablets Is a Virtual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Xarelto 15mg/20mg treatment initiation pack (Bayer Plc) Is a True Rivaroxaban 15mg tablets and Rivaroxaban 20mg tablets Inferred relationship Existential restriction modifier
Rivaroxaban 15mg tablets and Rivaroxaban 20mg tablets 49 tablet Has VMP True Rivaroxaban 15mg tablets and Rivaroxaban 20mg tablets Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start